| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
57,268 |
55,280 |
$4.37M |
| 20611 |
|
20,697 |
8,665 |
$774K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
1,375 |
1,305 |
$722K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,458 |
6,444 |
$721K |
| G9006 |
Coordinated care fee, home monitoring |
2,706 |
2,446 |
$692K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,097 |
6,657 |
$637K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,267 |
10,953 |
$528K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
820 |
799 |
$456K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,702 |
2,700 |
$215K |
| 96415 |
|
6,461 |
6,065 |
$204K |
| 73120 |
|
14,035 |
7,061 |
$168K |
| J0897 |
Injection, denosumab, 1 mg |
737 |
734 |
$157K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,117 |
4,836 |
$126K |
| 73620 |
|
12,941 |
6,515 |
$125K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,825 |
9,169 |
$121K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,999 |
4,726 |
$112K |
| J7332 |
Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg |
1,827 |
678 |
$94K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
3,267 |
1,075 |
$88K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
56 |
56 |
$82K |
| 73560 |
|
6,055 |
3,119 |
$70K |
| 20610 |
|
1,572 |
804 |
$50K |
| 20552 |
|
1,442 |
1,425 |
$39K |
| 20553 |
|
993 |
989 |
$37K |
| J3262 |
Injection, tocilizumab, 1 mg |
27 |
25 |
$36K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
1,499 |
452 |
$34K |
| 72100 |
|
2,034 |
2,033 |
$33K |
| 77080 |
|
1,545 |
1,541 |
$28K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,388 |
1,275 |
$28K |
| 99215 |
Prolong outpt/office vis |
235 |
233 |
$23K |
| 73030 |
|
1,403 |
753 |
$22K |
| 72040 |
|
968 |
968 |
$19K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,940 |
4,601 |
$14K |
| J0490 |
Injection, belimumab, 10 mg |
29 |
25 |
$11K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
1,013 |
268 |
$10K |
| 72200 |
|
635 |
382 |
$8K |
| 73502 |
|
288 |
146 |
$6K |
| 99205 |
Prolong outpt/office vis |
28 |
28 |
$5K |
| 72070 |
|
193 |
193 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,940 |
4,598 |
$2K |
| 96401 |
|
93 |
91 |
$2K |
| 73600 |
|
52 |
27 |
$478.32 |
| 20606 |
|
15 |
13 |
$456.05 |
| 99442 |
|
14 |
14 |
$395.04 |
| J9250 |
Methotrexate sodium, 5 mg |
1,264 |
467 |
$373.63 |
| 73100 |
|
28 |
14 |
$288.90 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$259.40 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
127 |
122 |
$162.76 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
128 |
123 |
$64.70 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
27 |
27 |
$41.77 |